Patient Corner

Anatomical Illustrations


Latest drug updates

  • 15 Dec 2017 - Drug Updates

Patient-related factors and 3 risk-based categories should be considered while prescribing antiepileptic drugs

Core advice from 2013 remains effective while switching between different manufacturers’ products of an oral antiepileptic drug.

  • 15 Dec 2017 - Drug Updates

Reports of some batches of gentamicin sulphate active pharmaceutical ingredient containing higher than expected histamine levels

Monitor patients closely for potential adverse reactions associated with increased levels of histamine.

  • 8 Nov 2017 - Drug Updates

Gabapentin (Neurontin): Risk of developing respiratory depression without concomitant use of opioids

Advise patients on gabapentin to seek medical help if they experience any trouble breathing or are taking shallow breaths.

  • 8 Nov 2017 - Drug Updates

Do not use Solu-Medrone 40 mg in patients with a known or suspected allergy to cows’ milk

Stop administration of product if any allergic symptoms occur and treat patient’s condition accordingly.

  • 31 Oct 2017 - Drug Updates

Isotretinoin (Roaccutane): Risk of sexual side effects like erectile dysfunction and decreased libido

Healthcare professionals should be aware of sexual and psychiatric adverse reactions associated with Isotretinoin.

  • 31 Oct 2017 - Drug Updates

Clozapine associated with risk of intestinal obstruction, faecal impaction, and paralytic ileus

Patients on antipsychotic drug clozapine are advised to report and treat constipation immediately.

  • 28 Sep 2017 - Drug Updates

Loperamide (Imodium): Overdoses of loperamide associated with risk of serious cardiovascular events

Naloxone should be given as an antidote in case of overdoses of loperamide.

  • 28 Sep 2017 - Drug Updates

Patients on warfarin should not use over-the-counter Miconazole oral gel (Daktarin)

Patients on warfarin should take prescription-only miconazole oral gel and should seek immediate medical attention if they experience any signs of bleeding.

  • 23 Aug 2017 - Drug Updates

Local and systemic administration of corticosteroids: risk of central serous chorioretinopathy

Report any blurred vision or other visual disturbances during corticosteroid treatment.

  • 31 Jul 2017 - Drug Updates

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Initiate daclizumab in restricted groups of patients with limited treatment options and closely monitor liver function.